These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27063063)

  • 21. Relation of metabolic syndrome with long-term mortality in acute and stable coronary disease.
    Arbel Y; Havakuk O; Halkin A; Revivo M; Berliner S; Herz I; Weiss-Meilik A; Sagy Y; Keren G; Finkelstein A; Banai S
    Am J Cardiol; 2015 Feb; 115(3):283-7. PubMed ID: 25499926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.
    Wu H; Xiong L; Xu Q; Wu J; Huang R; Guo Q; Mao H; Yu X; Yang X
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):749-55. PubMed ID: 26084271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact Of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up.
    Zafari N; Asgari S; Lotfaliany M; Hadaegh A; Azizi F; Hadaegh F
    Sci Rep; 2017 Oct; 7(1):14220. PubMed ID: 29079827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal cardiac structure and function in the metabolic syndrome: a population-based study.
    Aijaz B; Ammar KA; Lopez-Jimenez F; Redfield MM; Jacobsen SJ; Rodeheffer RJ
    Mayo Clin Proc; 2008 Dec; 83(12):1350-7. PubMed ID: 19046554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography.
    Tsang TS; Barnes ME; Gersh BJ; Takemoto Y; Rosales AG; Bailey KR; Seward JB
    J Am Coll Cardiol; 2003 Oct; 42(7):1199-205. PubMed ID: 14522480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Do isolated hypertension and metabolic syndrome have equal risk of stroke in Chinese adults?].
    Xing XY; Li GW; Yao CH; Hu YS; Zhai FY; Rao KQ; Kong LZ;
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2679-82. PubMed ID: 19260156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study.
    Lieske JC; de la Vega LS; Gettman MT; Slezak JM; Bergstralh EJ; Melton LJ; Leibson CL
    Am J Kidney Dis; 2006 Dec; 48(6):897-904. PubMed ID: 17162144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study.
    Behboudi-Gandevani S; Ramezani Tehrani F; Hosseinpanah F; Khalili D; Cheraghi L; Kazemijaliseh H; Azizi F
    Fertil Steril; 2018 Dec; 110(7):1377-1386. PubMed ID: 30503137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study.
    Pontiroli AE; Zakaria AS; Mantegazza E; Morabito A; Saibene A; Mozzi E; Micheletto G;
    Cardiovasc Diabetol; 2016 Feb; 15():39. PubMed ID: 26922059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of all-cause mortality in abdominal obesity phenotypes: Tehran Lipid and Glucose Study.
    Doustmohamadian S; Serahati S; Barzin M; Keihani S; Azizi F; Hosseinpanah F
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):241-248. PubMed ID: 28139376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
    Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
    JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Runzo C; Prina Cerai S; Pagano G; Cavallo-Perin P;
    Diabetes Care; 2004 Nov; 27(11):2689-94. PubMed ID: 15505006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.
    Kutkienė S; Petrulionienė Ž; Laucevičius A; Petrylaitė M; Maskeliūnaitė D; Puronaitė R; Kovaitė M; Kalibaitaitė I; Rinkūnienė E; Dženkevičiūtė V; Kasiulevičius V
    Lipids Health Dis; 2018 Apr; 17(1):88. PubMed ID: 29673349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Cohort Study on Prediction of Incidence of All-Cause Mortality by Metabolic Syndrome.
    Li Z; Yang X; Yang J; Yang Z; Wang S; Sun F; Zhan S
    PLoS One; 2016; 11(5):e0154990. PubMed ID: 27195697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between metabolic diseases and all-cause and cardiovascular death in an elderly male population during a 15-year follow-up].
    Sun B; Shao Y; Li J; Tian H; Li C
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):913-8. PubMed ID: 24854911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population.
    Noto D; Cefalù AB; Barbagallo CM; Ganci A; Cavera G; Fayer F; Palesano O; Spina R; Valenti V; Altieri GI; Caldarella R; Giammanco A; Termini R; Burrascano M; Crupi G; Falletta A; Scafidi V; Sbordone D; La Seta F; Averna MR;
    Nutr Metab Cardiovasc Dis; 2016 Nov; 26(11):1020-1025. PubMed ID: 27511705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.